Literature DB >> 21786821

Assembly and targeting of liposomal nanoparticles encapsulating quantum dots.

Rajesh Mukthavaram1, Wolf Wrasidlo, David Hall, Santosh Kesari, Milan Makale.   

Abstract

Quantum dots (QDs) are attracting intense interest as fluorescence labeling agents for biomedical imaging because biocompatible coatings and relatively nontoxic rare earth metal QDs have emerged as possible options. QD photoemissions are bright, of narrow wavelength range, and very stable. We sought to encapsulate QDs within targeted PEGylated liposomes to reduce their propensity for liver uptake and to amplify the already strong QD emission signal. A novel lipid-QD conjugate initialized a process by which lipids in solution coalesced around the QDs. The liposomal structure was confirmed with size measurements, SEM, and IR spectroscopy. PEGylated QD liposomes injected into a xenograft tumor model largely cleared from the body within 24 h. Residual liver labeling was low. Targeted QD liposomes exhibited robust tumor labeling compared with controls. This study highlights the potential of these near IR emitting QD liposomes for preclinical/clinical applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21786821      PMCID: PMC3160765          DOI: 10.1021/bc200201e

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  33 in total

1.  A new PEG-lipid conjugate micelle for encapsulation of CdSe/ZnS quantum dots.

Authors:  Yon-Hwan Kim; Elango Subramanyam; Jeong Hyuk Im; Kang Moo Huh; Hye Choi; Joon Sig Choi; Yong-Kyu Lee; Sung-Woo Park
Journal:  J Nanosci Nanotechnol       Date:  2010-05

2.  Whole-body, real-time preclinical imaging of quantum dot fluorescence with time-gated detection.

Authors:  Andrzej May; Srabani Bhaumik; Sanjiv S Gambhir; Chun Zhan; Siavash Yazdanfar
Journal:  J Biomed Opt       Date:  2009 Nov-Dec       Impact factor: 3.170

3.  Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides.

Authors:  K Remaut; B Lucas; K Braeckmans; J Demeester; S C De Smedt
Journal:  J Control Release       Date:  2006-11-07       Impact factor: 9.776

4.  Functionalized near-infrared quantum dots for in vivo tumor vasculature imaging.

Authors:  Rui Hu; Ken-Tye Yong; Indrajit Roy; Hong Ding; Wing-Cheung Law; Hongxing Cai; Xihe Zhang; Lisa A Vathy; Earl J Bergey; Paras N Prasad
Journal:  Nanotechnology       Date:  2010-03-16       Impact factor: 3.874

5.  Bioimaging for targeted delivery of hyaluronic Acid derivatives to the livers in cirrhotic mice using quantum dots.

Authors:  Ki Su Kim; Wonhee Hur; Sang-Jun Park; Sung Woo Hong; Jung Eun Choi; Eun Ji Goh; Seung Kew Yoon; Sei Kwang Hahn
Journal:  ACS Nano       Date:  2010-06-22       Impact factor: 15.881

6.  Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX.

Authors:  Martin Löning; Heyke Diddens; Wolfgang Küpker; Klaus Diedrich; Gereon Hüttmann
Journal:  Cancer       Date:  2004-04-15       Impact factor: 6.860

7.  Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice.

Authors:  Peng Zou; Songbo Xu; Stephen P Povoski; Anna Wang; Morgan A Johnson; Edward W Martin; Vish Subramaniam; Ronald Xu; Duxin Sun
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

8.  Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis.

Authors:  Eric A Murphy; Bharat K Majeti; Leo A Barnes; Milan Makale; Sara M Weis; Kimberly Lutu-Fuga; Wolfgang Wrasidlo; David A Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

9.  Predicting in vivo fluorescence lifetime behavior of near-infrared fluorescent contrast agents using in vitro measurements.

Authors:  Walter J Akers; Mikhail Y Berezin; Hyeran Lee; Samuel Achilefu
Journal:  J Biomed Opt       Date:  2008 Sep-Oct       Impact factor: 3.170

10.  Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity.

Authors:  Debbie Liao; Ze Liu; Wolfgang Wrasidlo; Tingmei Chen; Yunping Luo; Rong Xiang; Ralph A Reisfeld
Journal:  Nanomedicine       Date:  2011-03-17       Impact factor: 5.307

View more
  5 in total

Review 1.  Quantum dot-based nanoprobes for in vivo targeted imaging.

Authors:  Y Zhu; H Hong; Z P Xu; Z Li; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 2.  Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.

Authors:  Anish Babu; Amanda K Templeton; Anupama Munshi; Rajagopal Ramesh
Journal:  AAPS PharmSciTech       Date:  2014-02-19       Impact factor: 3.246

3.  Quantiosomes as a multimodal nanocarrier for integrating bioimaging and Carboplatin delivery.

Authors:  Chwan-Fwu Lin; Chih-Jen Wen; Ibrahim A Aljuffali; Chun-Lin Huang; Jia-You Fang
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

4.  Quantum Dots Encapsulated with Canine Parvovirus-Like Particles Improving the Cellular Targeted Labeling.

Authors:  Dan Yan; Bin Wang; Shiqi Sun; Xia Feng; Ye Jin; Xueping Yao; Suizhong Cao; Huichen Guo
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

Review 5.  Design and Application of Near-Infrared Nanomaterial-Liposome Hybrid Nanocarriers for Cancer Photothermal Therapy.

Authors:  Pan Liang; Linshen Mao; Yanli Dong; Zhenwen Zhao; Qin Sun; Maryam Mazhar; Yining Ma; Sijin Yang; Wei Ren
Journal:  Pharmaceutics       Date:  2021-12-03       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.